Search

Search Results

• IL-1Ra: its role in rheumatoid arthritis

  M. Cutolo

  41-45

  https://doi.org/10.4081/reumatismo.2004.1s.41

  1705

  PDF: 2412

• Rheumatoid arthritis and atherosclerosis

  B. Seriolo, A. Sulli, B. Burroni, M. Cutolo

  140-146

  https://doi.org/10.4081/reumatismo.2003.140

  2039

  PDF: 3114

• Diagnostic and prognostic value of antibodies to cyclic citrullinated peptide (Anti-CCP) in rheumatoid arthritis

  G.L. Erre, A. Tocco, R. Faedda, A. Cossu, A. Carcassi

  118-123

  https://doi.org/10.4081/reumatismo.2004.118

  1171

  PDF: 5921

• Socio-demographic aspects and therapeutic pathways in patients with rheumatoid arthritis in Italy

  F. Salaffi, C.M. Vaccaro, T. Manacorda, L. Pardini, C.M. Montecucco

  197-211

  https://doi.org/10.4081/reumatismo.2009.197

  1286

  PDF: 972
• 

  Psoriasis and family history of psoriasis may not affect disease severity of rheumatoid arthritis

  N. Şen, R. Mercan, G. Geçmez, B. Ediz, O. Volkan, S. Yilmaz-Oner, M.E. Tezcan

  07-02-2022

  https://doi.org/10.4081/reumatismo.2021.1453

  6084

  PDF: 819

• Early rheumatoid arthritis

  F. Atzeni, P. Sarzi-Puttini

  100-117

  https://doi.org/10.4081/reumatismo.2007.100

  1803

  PDF: 2169

• TNFa inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects

  I. Cavazzana, F. Bobbio-Pallavicini, C. Bazzani, E. Bravi, S. Zingarelli, A. Ceribelli, R. Caporali, R. Cattaneo, F. Franceschini, C. Montecucco

  275-282

  https://doi.org/10.4081/reumatismo.2006.275

  1208

  PDF: 1000
• 

  Thermal alterations in patients with inflammatory diseases: a comparison between psoriatic and rheumatoid arthritis

  A. Capo, J. Di Paolo, E. Celletti, E. Ismail, A. Merla, P. Amerio

  225-231

  20-12-2018

  https://doi.org/10.4081/reumatismo.2018.1050

  1900

  PDF: 1167
• 

  Extra-articular rheumatoid arthritis

  E. Marcucci, E. Bartoloni, A. Alunno, M.C. Leone, G. Cafaro, F. Luccioli, V. Valentini, E. Valentini, G.M.C. La Paglia, A.F. Bonifacio, R. Gerli

  212-224

  20-12-2018

  https://doi.org/10.4081/reumatismo.2018.1106

  10054

  PDF: 4888

• B Lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis

  L. Quartuccio, M. Fabris, G. Ferraccioli

  143-146

  https://doi.org/10.4081/reumatismo.2004.143

  1618

  PDF: 1128

• Case report: rheumatoid arthritis and large granular lymphocytes syndrome

  F. Ingegnoli, M. Arreghini, B. Panni, R. Capra, F. Galbiati, P. Bonara, A. Marchesoni

  357-360

  https://doi.org/10.4081/reumatismo.2002.357

  1215

  PDF: 2194

• The subclinical involvement of the lung in rheumatoid arthritis: evaluation by high-resolution computed tomography

  M. Carotti, F. Salaffi, P. Manganelli, L. Salvolini, E. Bichi Secchi, S. De Berardinis

  280-288

  https://doi.org/10.4081/reumatismo.2001.280

  1287

  PDF: 1758

• PO:06:078 | Is difficult-to-treat rheumatoid arthritis less severe in patients with autoantibody-negative disease? retrospective analysis from a monocentric cohort. Bernardo D'Onofrio¹, Maria Chiara Ditto¹, Francesco Ghellere¹, Giacomo Tanti¹, Salvatore Panaro¹, Enrico Fusaro¹, Simone Parisi¹. | ¹AOU Città della Salute e della Scienza, Torino, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2013

  117
• 

  Novel autoantibodies in rheumatoid arthritis

  A.F. Bonifacio, A. Alunno, G.M.C. La Paglia, E. Valentini, M.C. Leone, E. Bartoloni, Roberto Gerli

  1-12

  01-04-2019

  https://doi.org/10.4081/reumatismo.2019.1102

  3434

  PDF: 1962

• Kidney involvement in rheumatoid arthritis

  A. Icardi, P. Araghi, M. Ciabattoni, U. Romano, P. Lazzarini, G. Bianchi

  76-85

  https://doi.org/10.4081/reumatismo.2003.76

  5824

  PDF: 7754

• Atherosclerosis and rheumatoid arthritis: relationships between intima-media thickness of the common carotid arteries and disease activity and disabilty

  G. Cuomo, P. Di Micco, A. Niglio, G. La Montagna, G. Valentini

  242-246

  https://doi.org/10.4081/reumatismo.2004.242

  1647

  PDF: 1352

• Clinical significance of fluoroscopic patterns specific for the mitotic spindle in patients with reumatic diseases

  P. Grypiotis, A. Ruffatti, M. Tonello, C. Winzler, C. Radu, S. Zampieri, M. Favaro, A. Calligaro, S. Todesco

  232-237

  https://doi.org/10.4081/reumatismo.2002.232

  1815

  PDF: 6021

• PO:12:184 | Atrioventricular conduction in chronic inflammatory arthritis: enhanced assessment by new electrocardiographic parameters Riccardo Accioli¹, Viola Salvini¹, Anna Cantore¹, Fabio Salvadori¹, Enrico Selvi², Virgina Berlengiero², Maurizio Acampa³, Alessandra Cartocci¹, Kateryna Miedviedieva¹, Decoroso Verrengia¹, Sciaila Bernardini¹, Michele Voglino¹, Giovanni Donati¹, Silvia Petri¹, Severino Gallo¹, Stefania Bisogno¹, Pier Leopoldo Capecchi¹, Pietro Enea Lazzerini¹ | ¹Division of Internal Medicine, Electroimmunology Unit, University Hospital of Siena, Italy; ²Division of Rheumatology, University Hospital of Siena, Italy; ³Stroke Unit, University Hospital of Siena, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2316

  23

• PO:26:088 | Rheumatologic immune-related adverse events from immune checkpoint inhibitors: a monocentric retrospective study Giulio Fraticelli^1|2, Nicola Farina^1|2, Alessandro Tomelleri^1|2, Marco Matucci Cerinic^1|2, Corrado Campochiaro^1|2, Lorenzo Dagna^1|2. | ¹Unit of Immunology, Rheumatology, Allergy and Rare Diseases UNIRAR, IRCCS San Raffaele Hospital, Milano, Italy; ²Inflammation, Fibrosis and Ageing Initiative INFLAGE, IRCCS San Raffaele Hospital, Milano, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2065

  129

• Soluble P-selectin levels in synovial fluid and serum from patients with psoriatic arthritis

  R. Scrivo, A. Spadaro, V. Riccieri, M. Bombardieri, M. Di Franco, D. Celestino, G. Valesini

  250-255

  https://doi.org/10.4081/reumatismo.2005.250

  1155

  PDF: 753

• Anti-TNFα agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients

  M. Filippini, C. Bazzani, S. Zingarelli, T. Ziglioli, M. Nuzzo, M. Vianelli, C. Biasini Rebaioli, R. Cattaneo, R. Gorla

  41-49

  https://doi.org/10.4081/reumatismo.2008.41

  1270

  PDF: 854

• PO:07:111 | Worsening of patient-reported outcomes is an early predictor of disease flare in patients with rheumatoid arthritis in course of treatment with conventional synthetic disease modifying anti-rheumatic drugs Ludovico De Stefano^1|2, Federica Sabatelli^1|2, Clelia Zampaglione^1|2, Blerina Xoxi², Antonio Manzo^1|2, Carlomaurizio Montecucco^1|2, Serena Bugatti^1|2. | ¹Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy; ²Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2022

  135

• PO:06:089 | Heat-not-burn cigarettes induce protein post-translational modifications (PTM): possible role in the pathogenesis of rheumatoid arthritis Claudia Ciancarella¹, Federica Maria Ucci¹, Valeria Manganelli², Elena Fasciolo², Roberta Priori¹, Fulvia Ceccarelli¹, Manuel Sergi³, Camilla Montesano³, Francesco Bartolini³, Maurizio Sorice², Cristiano Alessandri¹, Fabrizio Conti¹ | ¹Rheumatology Unit, Department of Internal Medicine, Anesthesiology and Cardiovascular Sciences, La Sapienza, Roma, Italy; ²Department of Experimental Medicine, La Sapienza University of Rome, Italy; ³Department of Chemistry, La Sapienza University Of Rome, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2301

  14
• 

  Assessment of patients affected by rheumatoid arthritis eligible for biotechnological agents and evaluation of their healthcare resource utilization and related costs

  L. Degli Esposti, V. Perrone, D. Sangiorgi, L. Sinigaglia

  5-14

  19-04-2021

  https://doi.org/10.4081/reumatismo.2021.1329

  4148

  PDF: 688

• Switching between TNFα antagonists in rheumatoid arthritis: personal experience and review of the literature

  R. Scrivo, F. Conti, F.R. Spinelli, S. Truglia, L. Magrini, M. Di Franco, F. Ceccarelli, G. Valesini

  107-117

  https://doi.org/10.4081/reumatismo.2009.107

  2055

  PDF: 1238

• Subclinical atherosclerosis in young patients with rheumatoid arthritis and low disease activity

  E. Bartoloni Bocci, S. Marchesi, F. Delle Monache, G. Vaudo, A. Giordano, F. Ragni Alunni, C. Angrisani, E. Mannarino, Y. Shoenfeld, R. Gerli

  16-21

  https://doi.org/10.4081/reumatismo.2005.16

  1090

  PDF: 1005
• 

  Treatment patterns of snti-TNF agents in Italy: an observational study

  L. Punzi, M. Matucci Cerinic, F. Cantini, G. Bagnato, U. Fiocco, C. Ferri, S. Bombardieri

  18-28

  https://doi.org/10.4081/reumatismo.2011.18

  1414

  PDF: 1035

• PO:20:005 | Sarcopenia and fracture risk in rheumatoid arthritis: correlation between SACR-F and fragility score measured by radiofrequency echographic multi-spectrometry Sara Torracchi¹, Pamela Bernardini¹, Daniela Melchiorre¹, Bianca Bossi¹, Dorilda Zeka¹, Francesca Nacci¹, Lorenzo Tofani¹, Serena Guiducci¹ | ¹SOD Reumatologia, Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2174

  149

• CO:09:5 | LDL-cholesterol goal attainment with ezetimibe and bempedoic acid in patients with rheumatoid arthritis: a simulation study in the Italian CORDIS cohort Alessandro Giollo¹, Kiren Khalid¹, Luca Bonanni², Nicola Ferri³, Gianluca Erre⁴, Matteo Piga⁵, Elena Bartoloni⁶, Andreina Manfredi⁷, Enno Giulio Favalli⁸, Maria Sole Chimenti⁹, Serena Guiducci¹⁰, Eleonora Celletti¹¹, Addolorata Corrado¹², Simone Parisi²⁰, Ivan Giovannini¹³, Elisa Gremese¹⁴, Garifallia Sakellariou¹⁵, Ombretta Viapiana¹⁶, Marco Fornaro¹⁹, Fabiola Atzeni¹⁷, Francesca Romana Spinelli¹⁸, Fabio Cacciapaglia¹⁹ | ¹Università di Padova Padova, Italy; ²UO Medicina Interna ULSS3 Mestre, Italy; ³Università di Padova, Department of Pharmaceutical and Pharmacological Sciences, University of Padova Padova, Italy; ⁴Università di Sassari Sassari, Italy; ⁵Università di Cagliari Cagliari, Italy; ⁶Univeristà degli studi di Perugia Perugia, Italy; ⁷Università di Modena e Reggio Emilia, UO di Reumatologia Ospedale Policlinico di Modena Reggio Emilia, Italy; ⁸IRCCS Humanitas Research Hospital, Rozzano Milano, Italy; ⁹Università Tor Vergata Roma, Italy; ¹⁰Università di Firenze Firenze, Italy; ¹¹Ospedale SS. Annunziata Chieti, Italy; ¹²Università degli studi di Foggia Foggia, Italy; ¹³Università di Udine, Clinica di Reumatologia Udine, Italy; ¹⁴Università degli studi di Milano Milano, Italy; ¹⁵Università degli Studi di Pavia Pavia, Italy; ¹⁶Università di Verona Verona, Italy; ¹⁷Università degli Studi di Messina Messina, Italy; ¹⁸Università La Sapienza Roma, Italy; ¹⁹Università di Bari, Reumatologia Universitaria Policlinico di Bari Bari, Italy; ²⁰S.C. di Reumatologia A.O.U. Città della Salute e della Scienza di Torino - Ospedale Molinette Torino, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2277

  11

• PO:07:096 | Safety of filgotinib in the treatment of rheumatoid arthritis: results from the multicentre SOFIA study Anna Giorgia Osele¹, Matteo Filippini², Eugenio Capparelli³, Eleonora Bruschi⁴, Bernd Raffeiner⁵, Silvano Bettio⁶, Mariangela Salvato¹, Federico Arru⁷, Massimiliano Limonta⁴, Paola Faggioli³, Elda Piovani², Eleonora Zaccara³, Alessandro Giollo¹, Margherita Zen¹ | ¹UOC Reumatologia, Azienda Ospedale-Università di Padova; ²UO Reumatologia e Immunologia Clinica, ASST Spedali Civili, Brescia; ³UOC Ruematologia, ASST Ovest Milanese, Legnano ^MI; ⁴SSD Reumatologia, ASST Papa Giovanni XXIII, Bergamo; ⁵Dipartimento di Reumatologia, Ospedale di Formazione Paracelsus ^ASDAA-SABES, Bolzano; ⁶Medicina Generale Unità 1^, Centro Regionale per le Malattie Rare Immunologiche e Reumatologiche, Ospedale Universitario Treviso; ⁷UO Medicina, ASL 3 Nuoro, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2136

  132

• Ultrasonographic assessment of the response to Etanercept treatment in patients with rheumatoid arthritis

  A. Iagnocco, C. Perella, F. Ceccarelli, E. Tripodo, C. Alessandri, L. Magrini, G. Valesini

  233-238

  https://doi.org/10.4081/reumatismo.2006.233

  1122

  PDF: 1058

• Severe drug hypersensitivity syndrome due to sulphasalazine in patient with rheumatoid arthritis

  M. Gutierrez, E. Filippucci, L. Bugatti, C. Bertolazzi, W. Grassi

  65-68

  https://doi.org/10.4081/reumatismo.2009.65

  1551

  PDF: 1149

• Disability and quality of life of patients with rheumatoid arthritis: assessment and perspectives

  F. Salaffi, A. Stancati

  87-106

  https://doi.org/10.4081/reumatismo.2004.1s.87

  1451

  PDF: 3462
• 

  Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE)

  G. Carlino, M. Fornaro, L. Santo, R. Bucci, A. Semeraro, L. Quarta, F. D'Onofrio, A. Marsico, C. Zuccaro, P.C. Falappone, D. Mazzotta, F.P. Cantatore, M. Muratore, F. Iannone

  24-30

  01-04-2019

  https://doi.org/10.4081/reumatismo.2019.1154

  1844

  PDF: 1260

• short history of anti-rheumatic therapy. IV. Corticosteroids

  G. Pasero, P. Marson

  292-299

  https://doi.org/10.4081/reumatismo.2010.292

  2064

  PDF: 2181

• Leishmaniasis in rheumatoid arthritis

  C. Pizzorni, M.E. Secchi, M. Cutolo

  235-239

  https://doi.org/10.4081/reumatismo.2007.235

  1677

  PDF: 1067

• PO:07:095 | Clinical impact of therapeutic modification following changes in AIFA reimbursement criteria for JAK inhibitors in patients with RA in remission/low disease activity: analysis of the multicenter JAK-SWAP RER study in Emilia-Romagna Marta Raschella¹, Giulia Furia¹, Martina Di Nunzio¹, Francesco Luca Renzullo², Francesco Girelli², Federica Pignatti³, Francesco Ursini³, Licia Vultaggio⁴, Pierluigi Cataleta⁴, Elena Bravi⁵, Eugenio Arrigoni⁵, Francesca Bergossi⁶, Enrica Vandelli⁷, Massimo Reta^6|7, Viola Magnani⁸, Andreina Manfredi^8|9, Giuseppe Germanò⁸, Alessandra Bortoluzzi¹, Marcello Govoni¹, Ettore Silvagni¹ | ¹Unità Operativa Complessa di Reumatologia, Dipartimento di Scienze Mediche, Università degli Studi di Ferrara e Azienda Ferrara; ²UOS Reumatologia, Ospedale GB Morgagni, Forlì; ³UOC Reumatologia, Istituto ortopedico Rizzoli, Bologna; ⁴UO Reumatologia, AUSL Romagna Ospedale di Ravenna; ⁵UO Reumatologia, Azienda USL di Piacenza; ⁶Reumatologia Osp. Maggiore, Bologna; ⁷UO Medicina Interna ad Indirizzo Reumatologico Interaziendale ^SC AUSL Bologna, IRCCS Policlinico di SantOrsola, Bologna; ⁸U.O Reumatologia, Santa Maria Nuova di Reggio Emilia; ⁹Università degli studi di Modena e Reggio Emilia, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2135

  149
• 

  Association between red cell distribution width and response to methotrexate in rheumatoid arthritis

  M. Bellan, D. Soddu, E. Zecca, A. Croce, R. Bonometti, R. Pedrazzoli, D. Sola, C. Rigamonti, L.M. Castello, G.C. Avanzi, M. Pirisi, P.P. Sainaghi

  16-20

  10-04-2020

  https://doi.org/10.4081/reumatismo.2020.1243

  2031

  PDF: 876

• The rehabilitative approach in rheumatoid arthritis

  G. Arioli, S. Maddali Bongi, N. Pappone

  242-248

  https://doi.org/10.4081/reumatismo.2008.242

  1947

  PDF: 2060

• Correlation between radiographic, echographic and MRI changes and rheumatoid arthritis progression

  M.A. Cimmino, M. Parodi, E. Silvestri, G. Garlaschi

  28-40

  https://doi.org/10.4081/reumatismo.2004.1s.28

  1131

  PDF: 3005

• Rheumatoid arthritis: frequency of hospitalization and evaluation of economic burden

  A. Ciocci, L. Buratti, G. Coari, M. Di Franco, A.M. Iagnocco, M.T. Mauceri, A. Serio

  215-222

  https://doi.org/10.4081/reumatismo.2001.215

  1219

  PDF: 801

• Prevalence of rheumatoid arthritis in North Sardinia: the Tempio Pausania’s study

  D. Marotto, M.E. Nieddu, A. Cossu, A. Carcassi

  273-276

  https://doi.org/10.4081/reumatismo.2005.273

  900

  PDF: 2351

• Analysis of foot structural damage in rheumatoid arthritis: clinical evaluation by validated measures and serological correlations

  D. Biscontini, E. Bartoloni Bocci, R. Gerli

  48-53

  https://doi.org/10.4081/reumatismo.2009.48

  1587

  PDF: 1105

• Analysis of the kinetic of expression of tristetraprolin and HuR by rheumatoid arthritis patients pheripheral blood mononuclear cells stimulated with lipopolysaccharide

  M. Fabris, B. Tolusso, E. Gremese, P. Tomietto, G. Ferraccioli

  94-103

  https://doi.org/10.4081/reumatismo.2004.94

  1522

  PDF: 988
• 

  Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study

  M. Rossini, O. Viapiana, M. Vitiello, N. Malavolta, G. La Montagna, S. Maddali Bongi, O. Di Munno, R. Nuti, C.U. Manzini, C. Ferri, L. Bogliolo, A. Mathieu, F. Cantatore, A. Del Puente, M. Muratore, W. Grassi, B. Frediani, G. Saviola, P. Delvino, L. Mirone, G. Ferraccioli, G. Tripi, I. Piazza, D. Gatti

  30-39

  22-05-2017

  https://doi.org/10.4081/reumatismo.2017.922

  5038

  PDF: 3262

• Stress response system and personality in rheumatoid arthritis patients

  C. Prete, F. Briano, C. Pizzorni, A. Sulli, M. Marcenaro, M. Cutolo

  204-209

  https://doi.org/10.4081/reumatismo.2001.204

  1521

  PDF: 945

• Unexpected and persistent depletion of B lymphocytes CD20 following a minimum dose of anti-CD20 antibody (Rituximab)

  V. Bruzzese, J. Pepe

  306-308

  https://doi.org/10.4081/reumatismo.2009.306

  1098

  PDF: 871

• Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies

  I. Cavazzana, F. Franceschini, E. Danieli, M. Frassi, M. Vianelli, R. Gorla, P. Airò, R. Cattaneo

  267-272

  https://doi.org/10.4081/reumatismo.2005.267

  1217

  PDF: 1837

• PO:06:081 | Safety of JAK inhibitors compared to non-TNF-targeted biologic therapies in rheumatoid arthritis patients who are inadequate responders to TNF inhibitors Lorenzo Di Luozzo¹, Alessandro Giollo¹, Mariangela Salvato¹, Francesca Frizzera¹, Kiren Khalid¹, Margherita Zen¹, Andrea Doria¹ | ¹Azienda ospedaliera universitaria di Padova, unità di Reumatologia, Padova, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2298

  29

• Blocking TNF in vitro with infliximab determines the inhibition of expansion and interferon gamma production of Vγ9/Vδ2 T lymphocytes from patients with active rheumatoid arthritis. A role in the susceptibility to tuberculosis?

  A.R. Giardina, A. Accardo-Palumbo, F. Ciccia, A. Ferrante, A. Principato, R. Impastato, G. Triolo

  21-26

  https://doi.org/10.4081/reumatismo.2009.21

  1554

  PDF: 1200